CN Patent

CN1268137A — 治疗神经失调的咪唑并嘧啶和咪唑并吡啶

Assigned to Bristol Myers Squibb Pharma Co · Expires 2000-09-27 · 26y expired

What this patent protects

式(Ⅰ)的促肾上腺皮质激素释放因子(CRF)拮抗剂和它们在哺乳动物上治疗精神紊乱和神经疾病、与焦虑相关的紊乱、创伤后应激紊乱、核上麻痹和饮食紊乱以及治疗免疫的、心血管的或与心脏相关的疾病和与精神病理性障碍和应激有关的肠道超敏反应的用途。

USPTO Abstract

式(Ⅰ)的促肾上腺皮质激素释放因子(CRF)拮抗剂和它们在哺乳动物上治疗精神紊乱和神经疾病、与焦虑相关的紊乱、创伤后应激紊乱、核上麻痹和饮食紊乱以及治疗免疫的、心血管的或与心脏相关的疾病和与精神病理性障碍和应激有关的肠道超敏反应的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN1268137A
Jurisdiction
CN
Classification
—
Expires
2000-09-27
Drug substance claim
No
Drug product claim
No
Assignee
Bristol Myers Squibb Pharma Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.